Please login to the form below
Fosun Pharma
This page shows the latest Fosun Pharma news and features for those working in and with pharma, biotech and healthcare.
Kite bags $90m upfront in two Asian deals for lead CAR-T drug
Partners with Daiichi Sankyo and Fosun Pharma to focus in on non-Hodgkin lymphoma. ... In China, Kite has formed a joint venture with Chinese drugmaker Fosun Pharma to develop lead chimeric antigen receptor T cell (CAR-T) therapy axicabtagene ciloleucel
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
1, 600. Valeant. L'Oreal. Divestment. CeraVe AcneFree AMBI. 1, 300. Forward Pharma. ... 160. Kite Pharma. Fosun Pharma. Formation of a JV. Autologous T-cell therapies in cancer.
-
Unravelling China’s healthcare sector
Shanghai Fosun Pharma and Jiangsu Hengrui have both established R&D hubs in the US and partner with top research institutions for innovator drug research. . ... Jiangsu Hengrui Pharma and Hutchison Medi Pharma are running clinical trials in overseas
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Account Manager – Healthcare advertising
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary plus benefits
-
Events Executive
-
DOE
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
- Client Services Director- Flexible Working
-
Negotiable
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- AbbVie/Allergan's merger faces public opposition
- How can we realise the benefits of patient engagement?
- Half of European cancer drug trials ‘biased’, says BMJ
- Four Health and ARK among winners at PM Society Digital Awards
- Democrats’ final pricing plan announced, 250 drugs targeted
- Insys gets bankruptcy court okay for Subsys sale
- Breath test could predict response to immunotherapy
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
